Wilmer Eye Institute

Novel glaucoma treatments factor in scleral behaviorInnovations in sustained-drug delivery and neuroprotection are bringing glaucoma specialists one step closer to additional therapeutic options.
Neuroprotective drug may be possible NAION therapyNon-arteritic ischemic optic neuropathy can be difficult to treat. A new drug under investigation aims to prevent further loss of vision from the condition.
Tracking treatment adherence in newly diagnosed open-angle glaucoma
Tracking treatment adherence in newly diagnosed open-angle glaucomaAn analysis of U.S. claims data reveals a substantial proportion of patients (17%) remained untreated 4 years after their initial diagnosis of open-angle glaucoma.
Are we ophthalmologists in the eye of the storm?
Are we ophthalmologists in the eye of the storm?This meteorological phenomenon is considered to have given rise to one of the most commonly misused phrases in the English language. Some people think the phrase means that the situation is a tumultuous one, as when The Economist magazine reported: “French bank shares, which have been in the eye of the storm, recovered sharply (BNP Paribas was up 13% on the day while Societe Generale rose by 5%).”
Improving the prognosis of uveal melanomaAbout one-half of people diagnosed with uveal melanoma ultimately develop metastatic disease. A look at survival rates for patients with uveal melanoma indicate that not much has changed in the past several decades or even for the past 100-plus years. Nevertheless, there is good reason to be optimistic about the future considering the recent developments and ongoing research in this field, said Mary Beth Aronow, MD, at Ocular Oncology and Pathology 2016.
Seasons change but athletic eye injuries occur year-round
The lens regrowth hypothesisIn March 2016, the lens regrowth hypothesis was transformed into a distinct clinical possibility. Investigators from China and the United States reported their findings in Nature detailing a series of experiments in animals and children up to 2 years of age
‘Super formula’ maximizes accuracy for IOL powersAn IOL “super formula” may broaden the conceptual understanding of IOL calculations, improve clinical outcomes for patients, and stimulate further progress in IOL formula research.
Rethinking the EHR system: The most important componentsDocumenting practice flow and needs is a critical step in preparation for choosing or replacing an electronic health record system.
Artificial cornea may be alternative to repeat PK in certain patientsFindings of a retrospective case review show that eyes that underwent implantation of the Boston Type 1 keratoprosthesis had greater improvement in visual acuity than those undergoing repeat donor corneal transplantation.